TITAN PHARMACEUTICALS INC (TTNP)

US8883147055 - Common Stock

6.7  0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
184.00K560.00K1.53M4.84M2.61M
Cost Of Goods
N/A0.00200.00K470.00K0.00
Gross Profit
N/A560.00K1.33M4.37M2.61M
Operating Expenses
7.46M10.79M10.68M11.72M10.49M
Research and Development
1.91M4.76M5.69M5.92M5.08M
Selling, General, and Administrative Expenses
5.55M6.03M4.99M5.80M5.40M
Operating Income
-7.28M-10.24M-9.35M-7.35M-7.88M
Interest Income/Expense
5.00K50.00K0.00280.00K140.00K
Other Income/Expense
-52.00K-20.00K-80.00K-260.00K20.00K
Non Recurring Items
N/A0.00660.00K-80.00K230.00K
Income Before Taxes
-5.57M-10.21M-8.78M-7.41M-7.49M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-5.57M-10.21M-8.78M-18.24M-16.46M
EBITDA
-7.17M-10.04M-9.13M-7.06M-7.64M
 
Per Share Data
EPS Diluted Total Ops
-7.41-0.76-0.90-4.83-21.37
Non GAAP EPS
N/AN/AN/A-5.96-29.40
 
Statistics
Gross Profit Margin
N/A100.00%86.93%90.29%100.00%
Profit Margin
-3026.63%-1823.21%-573.86%-376.86%-630.65%
Operating Profit Margin
-3954.89%-1828.57%-611.11%-151.86%-301.92%

All data in USD

Charts